Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
BioNano Genomics Inc (BNGO)
NASDAQ:BNGO
BioNano Genomics (BNGO) Stock Price & Analysis
8,744 Followers
BNGO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.71 - $8.20
Previous Close$0.98
Volume622.78K
Average Volume (3M)1.43M
Market Cap
$63.88M
Enterprise Value$12.23M
Total Cash (Recent Filing)$63.60M
Total Debt (Recent Filing)$10.14M
Price to Earnings (P/E)-0.2
Beta2.83
Next Earnings
Aug 08, 2024EPS Estimate
-$0.47Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-6.01
Shares Outstanding66,856,804
10 Day Avg. Volume902,631
30 Day Avg. Volume1,433,496
Standard Deviation0.80
R-Squared0.03
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)0.81
Price to Sales (P/S)8.00
Price to Cash Flow (P/CF)-0.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.36
Enterprise Value/Gross Profit2.06
Enterprise Value/Ebitda-0.06
Forecast
1Y Price Target
$4.50Price Target Upside370.96% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
BioNano Genomics News
PremiumCompany Announcements
BioNano Genomics Launches Offering to Bolster FinancesBulls Say, Bears Say
Bulls Say
Earnings GrowthBionano reported significant revenue growth with its latest earnings, showcasing a strong upward trajectory in financial performance.
Operational EfficiencyBionano's strategic cost savings initiatives have successfully reduced operational expenses, enhancing profit potential.
Product ExpansionThe expansion of Bionano's Saphyr installed base signifies increasing market adoption and potential for future revenue streams.
Bears Say
Company OutlookDespite the potential of Saphyr technology, ongoing capital needs and financial instability have led to a downgrade of BNGO shares to Hold.
Financial StrategyThe company may need to leverage its ATM, risking substantial dilution for current shareholders due to the low share price.
Stock ValuationBNGO shares have declined significantly, indicating a potential loss of investor confidence.
---
Ownership Overview
8.91% Insiders
3.05% Mutual Funds
3.03% Other Institutional Investors
85.01% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
BNGO FAQ
What was BioNano Genomics Inc’s price range in the past 12 months?
BioNano Genomics Inc lowest stock price was $0.71 and its highest was $8.20 in the past 12 months.
What is BioNano Genomics Inc’s market cap?
Currently, no data Available
When is BioNano Genomics Inc’s upcoming earnings report date?
BioNano Genomics Inc’s upcoming earnings report date is Aug 08, 2024 which is in 89 days.
How were BioNano Genomics Inc’s earnings last quarter?
BioNano Genomics Inc released its earnings results on May 08, 2024. The company reported -$0.6 earnings per share for the quarter, beating the consensus estimate of -$0.644 by $0.044.
Is BioNano Genomics Inc overvalued?
According to Wall Street analysts BioNano Genomics Inc’s price is currently Undervalued.
Does BioNano Genomics Inc pay dividends?
BioNano Genomics Inc does not currently pay dividends.
What is BioNano Genomics Inc’s EPS estimate?
BioNano Genomics Inc’s EPS estimate is -$0.47.
How many shares outstanding does BioNano Genomics Inc have?
BioNano Genomics Inc has 66,856,804 shares outstanding.
What happened to BioNano Genomics Inc’s price movement after its last earnings report?
BioNano Genomics Inc reported an EPS of -$0.6 in its last earnings report, beating expectations of -$0.644. Following the earnings report the stock price went up 6.522%.
Which hedge fund is a major shareholder of BioNano Genomics Inc?
Among the largest hedge funds holding BioNano Genomics Inc’s share is GMT Capital Corp. It holds BioNano Genomics Inc’s shares valued at 1M.
---
BioNano Genomics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$4.50 (370.96% Upside)
$4.50 (370.96% Upside)
Blogger Sentiment
Neutral
BNGO Sentiment 50%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 6.0 Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 4.5%
Last 30 Days ▼ 4.5%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-87.70%
12-Months-Change
Fundamentals
Return on Equity
-144.33%
Trailing 12-Months
Asset Growth
-45.92%
Trailing 12-Months
Company Description
BioNano Genomics Inc
BioNano Genomics, Inc. is a life sciences instrumentation company, which focuses on genome analysis space. The firm engages in the development and marketing of Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics. The company was founded by Han Cao in October 2003 and is headquartered in San Diego, CA.
---
BNGO Earnings Call
Q1 2024
0:00 / 0:00
---
BNGO Stock 12 Month Forecast
Average Price Target
$4.50
▲(370.96% Upside)
Technical Analysis
Best Analysts Covering BNGO
1 Year
1 Year Success Rate
0/10 ratings generated profit
1 Year Average Return
-52.26%
reiterated a buy rating 2 days ago
Copying Sung Ji Nam's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -52.26% per trade.
---